Evidence map›Paper›PMID 27338297›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.

Clio P Mavragani, Irina Sagalovskiy, Qiu Guo, Adrianos Nezos, Efstathia K Kapsogeorgou, Pin Lu, Jun Liang Zhou, Kyriakos A Kirou, Surya V Seshan, Haralampos M Moutsopoulos and 1 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 183 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Repetitive Sequence Stability in Embryonic Stem Cells.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Clio P MavraganiHospital for Special Surgery, New York, New York, and National and Kapodistrian University of Athens, Athens, Greece.
Irina SagalovskiyHospital for Special Surgery, New York, New York.
Qiu GuoHospital for Special Surgery, New York, New York.
Adrianos NezosNational and Kapodistrian University of Athens, Athens, Greece.
Efstathia K KapsogeorgouNational and Kapodistrian University of Athens, Athens, Greece.
Pin LuHospital for Special Surgery, New York, New York.
Jun Liang ZhouHospital for Special Surgery, New York, New York.
Kyriakos A KirouHospital for Special Surgery, New York, New York.
Surya V SeshanWeill Cornell Medical College, New York, New York.
Haralampos M MoutsopoulosNational and Kapodistrian University of Athens, Athens, Greece.
Mary K CrowHospital for Special Surgery, New York, New York. crowm@hss.edu.
Hospital for Special Surgery · USNational and Kapodistrian University of Athens · GRCornell University · US

Funding

IMMUNOLOGY RESEARCH TRAINING PROGRAMT32AI007621 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL · 1999 to 2014
$3.4M
RHEUMATOLOGY TRAININGT32AR007517 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI CROW, MARY K · 1986 to 2014
$2.2M
Interferon in Systemic Lupus ErythematosusR01AI059893 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI CROW, MARY K · 2006 to 2010
$2.1M
Identification of Rheumatic Disease GenesR21AR050673 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI CROW, MARY K · 2003 to 2004
$170k
NIAID NIH HHS R01 AI059893NIAID NIH HHS T32 AI007621NIAMS NIH HHS R21 AR050673NIAMS NIH HHS T32 AR007517
6 · The paper itself

Abstract

objectiveIncreased expression of type I interferon (IFN) and a broad signature of type I IFN-induced gene transcripts are observed in patients with systemic lupus erythematosus (SLE) and other systemic autoimmune diseases. To identify disease-relevant triggers of the type I IFN pathway, this study sought to investigate whether endogenous virus-like genomic repeat elements, normally silent, are expressed in patients with systemic autoimmune disease, and whether these retroelements could activate an innate immune response and induce type I IFN.

methodsExpression of type I IFN and long interspersed nuclear element 1 (LINE-1; L1) was studied by polymerase chain reaction, Western blotting, and immunohistochemistry in samples of kidney tissue from patients with lupus nephritis and minor salivary gland (MSG) tissue from patients with primary Sjögren's syndrome (SS). Induction of type I IFN by L1 was investigated by transfection of plasmacytoid dendritic cells (PDCs) or monocytes with an L1-encoding plasmid or L1 RNA. Involvement of innate immune pathways and altered L1 methylation were assessed.

resultsLevels of L1 messenger RNA transcripts were increased in lupus nephritis kidneys and in MSG tissue from patients with SS. Transcript expression correlated with the expression of type I IFN and L1 DNA demethylation. L1 open-reading frame 1/p40 protein and IFNβ were expressed in MSG ductal epithelial cells and in lupus nephritis kidneys, and IFNα was detected in infiltrating PDCs. Transfection of PDCs or monocytes with L1-encoding DNA or RNA induced type I IFN. Inhibition of Toll-like receptor 7 (TLR-7)/TLR-8 reduced the induction of IFNα by L1 in PDCs, and an inhibitor of IKKε/TANK-binding kinase 1 abrogated the induction of type I IFN by L1 RNA in monocytes.

conclusionL1 genomic repeat elements represent endogenous nucleic acid triggers of the type I IFN pathway in SLE and SS and may contribute to initiation or amplification of autoimmune disease.

Indexed as

AdultAgedAutoimmune DiseasesBlotting, WesternDendritic CellsDNA MethylationFemaleHumansI-kappa B KinaseImmunity, InnateImmunohistochemistryInterferon-alphaInterferon-betaInterferon Type IKidneyLeukocytes, MononuclearI-kappa B KinaseInterferon-alphaInterferon-betaInterferon Type IProtein Serine-Threonine KinasesTBK1 protein, humanTLR7 protein, humanTLR8 protein, humanTLR9 protein, humanToll-Like Receptor 7Toll-Like Receptor 8Toll-Like Receptor 9

Identifiers

PMID27338297
PMCPMC5083133
OpenAlexW2542088537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.